Table 3.
Methodological quality items endorsed.
| Item | % |
|---|---|
| Random assignment of participants | 52% |
| Treatment standardized (e.g., manual) | 22% |
| Pretest post-test design | 100% |
| Follow-up rate (k = 17) | |
| ≤70% completed | 6% |
| 70–84% completed | 24% |
| ≥85% completed | 71% |
| Follow-up length | |
| ≤3 months | 87% |
| 3–5 months | 9% |
| ≥6 months | 4% |
| Representative sample | 4% |
| Participant who withdrew after randomization reported (k = 8) | 13% |
| Participants lost to follow-up after treatment reported (k = 9) | 22% |
| Anonymity | 0% |
| Intervention compliance | 35% |
| Treatment fidelity | 0% |
| Collateral verification | 9% |
| Objective measures used | 100% |
| Follow-up assessments blind to group assessment | 17% |
| Analyses controlled for baseline | 22% |